AS

Aortic stenosis is a congenital heart defect in dogs characterized by the abnormal narrowing of the area at or near the aortic valve, which impedes blood flow from the left ventricle into the aorta and out to the rest of the body. The most common form encountered in dogs is subaortic stenosis (SAS), where a ring or ridge of fibrous tissue develops just below the aortic valve in the left ventricular outflow tract. Less frequently, the obstruction occurs at the valve itself (valvular stenosis) or above the valve (supravalvular stenosis), though these presentations are comparatively rare in canines.

The condition develops during fetal growth or in the early weeks after birth, as abnormal tissue proliferates in the outflow region of the left ventricle. While some puppies are born with a fully formed obstruction, in many cases the fibrous ridge continues to develop and worsen during the first year of life. This progressive nature means that a puppy examined at eight weeks of age may have a barely detectable murmur that becomes significantly more pronounced by six to twelve months. Breeders and veterinarians must therefore exercise caution when clearing young puppies of heart disease based on a single early examination.

The hemodynamic consequences of aortic stenosis are significant. The narrowed outflow tract forces the left ventricle to generate substantially higher pressures to eject blood through the obstruction. Over time, this chronic pressure overload leads to concentric hypertrophy of the left ventricular wall, meaning the muscle thickens in response to the increased workload. While this compensatory mechanism initially maintains cardiac output, it ultimately compromises the heart's ability to function efficiently and predisposes the dog to a range of serious complications including arrhythmias and myocardial ischemia.

Aortic stenosis is recognized as one of the most common congenital heart defects in dogs and has been extensively studied in veterinary cardiology. The condition carries a strong genetic component in several large and giant breed dogs, with inheritance patterns suggesting a polygenic mode of transmission in breeds such as the Newfoundland. Understanding the nature and progression of this disease is essential for affected breed communities, as responsible breeding decisions represent the most effective strategy for reducing its prevalence.

The primary cause of aortic stenosis in dogs is genetic predisposition. Research has established that the condition is heritable, particularly in breeds such as the Newfoundland, where extensive pedigree analysis has demonstrated a genetic basis for the disease. The inheritance pattern is believed to be polygenic and potentially autosomal dominant with variable penetrance in some breeds, meaning that a dog carrying the genetic predisposition may develop the condition with varying degrees of severity or may pass the trait to offspring without being severely affected itself.

The pathogenesis involves the abnormal development of fibrous or fibromuscular tissue in the left ventricular outflow tract during embryonic development and early postnatal life. In subaortic stenosis, this tissue forms a discrete ridge, a fibrous ring, or in severe cases a tunnel-like narrowing beneath the aortic valve. The exact molecular mechanisms triggering this abnormal tissue growth remain under investigation, but the process appears to involve dysregulated proliferation of endocardial and subendocardial connective tissue cells during cardiac morphogenesis.

Breed predisposition is the most significant risk factor for developing aortic stenosis. Newfoundlands have the highest prevalence, followed by Golden Retrievers, Rottweilers, Boxers, and German Shepherds. Other breeds with elevated risk include the Bullmastiff, Great Dane, Bouvier des Flandres, Dogue de Bordeaux, and the Bull Terrier. While the condition occurs predominantly in large and giant breeds, it has been documented in medium-sized breeds as well. Dogs with a first-degree relative diagnosed with aortic stenosis carry a substantially increased risk of being affected.

Environmental factors have not been conclusively identified as contributing to the development of aortic stenosis, and the condition is considered overwhelmingly genetic in origin. However, the variable expressivity of the disease suggests that modifier genes, epigenetic factors, or developmental influences during gestation may play a role in determining the ultimate severity of the obstruction in any given individual. Nutritional status of the dam during pregnancy and other prenatal conditions may theoretically influence cardiac development, though direct evidence linking specific environmental exposures to aortic stenosis in dogs remains limited.

The clinical presentation of aortic stenosis in dogs varies dramatically depending on the severity of the obstruction. Dogs with mild stenosis may be completely asymptomatic throughout their lives, with the condition detected only incidentally when a veterinarian identifies a heart murmur during a routine physical examination. These mildly affected dogs often lead normal lives with no apparent exercise limitations or clinical signs, and the murmur may remain the only evidence of the underlying cardiac abnormality.

Dogs with moderate to severe aortic stenosis are more likely to exhibit clinical signs, though these may not become apparent until the dog is subjected to physical exertion. Exercise intolerance is one of the most commonly reported symptoms, manifesting as the dog tiring more quickly than expected during walks, play sessions, or other physical activities. Owners may notice that their dog pants excessively after minimal effort, lags behind on walks, or seems reluctant to engage in activities that previously caused no difficulty. Some dogs may experience episodes of weakness or lethargy that coincide with exertion.

Syncope, or fainting, is a particularly concerning symptom that occurs in dogs with more severe forms of the disease. These episodes result from the heart's inability to adequately increase cardiac output during exercise, leading to transient cerebral hypoperfusion. Syncopal episodes are typically brief, with the dog collapsing and then recovering within seconds to minutes, but they indicate significant hemodynamic compromise and carry prognostic significance. In some cases, syncope may be triggered by excitement or stress rather than physical activity alone.

In the most severe cases, dogs may develop signs of congestive heart failure, including coughing, increased respiratory rate or difficulty breathing, abdominal distension from fluid accumulation, and decreased appetite. Sudden death is unfortunately a well-recognized outcome in dogs with severe aortic stenosis, occurring due to fatal ventricular arrhythmias triggered by myocardial ischemia or fibrosis. This risk of sudden death exists even in dogs that have previously appeared clinically stable, making severe aortic stenosis a particularly concerning diagnosis for owners and veterinarians alike.

The diagnostic workup for aortic stenosis typically begins with the detection of a heart murmur during physical examination. The characteristic murmur of aortic stenosis is a systolic ejection murmur heard best at the left heart base, radiating cranially toward the thoracic inlet and often palpable as a precordial thrill in moderate to severe cases. The murmur intensity generally correlates with the severity of the obstruction, though this relationship is not absolute. Femoral pulse quality may be diminished or demonstrate a slow rise (pulsus parvus et tardus) in significantly affected dogs.

Echocardiography is the gold standard diagnostic tool for confirming aortic stenosis and assessing its severity. Two-dimensional echocardiography allows direct visualization of the subvalvular ridge or ring of fibrous tissue, the thickened left ventricular walls indicative of concentric hypertrophy, and any secondary changes to the aortic valve leaflets. Doppler echocardiography is essential for measuring the peak velocity of blood flow through the stenotic region, which is used to estimate the pressure gradient across the obstruction. A peak velocity below 2.0 meters per second is generally considered within normal limits for large breed dogs, while velocities exceeding 4.5 meters per second indicate severe stenosis.

Electrocardiography (ECG) may reveal findings consistent with left ventricular enlargement and can detect arrhythmias, particularly ventricular premature complexes, which are common in dogs with moderate to severe aortic stenosis. Holter monitoring, which records the heart rhythm continuously over a 24-hour period, provides valuable information about the frequency and complexity of arrhythmias and is particularly useful for risk stratification in affected dogs. The presence of frequent or complex ventricular arrhythmias is associated with an increased risk of sudden death.

Thoracic radiography may show left ventricular enlargement and post-stenotic dilation of the ascending aorta in affected dogs, though radiographic findings can be subtle in mild cases. Cardiac catheterization, while less commonly performed than echocardiography in clinical practice, allows direct measurement of pressure gradients across the stenotic region and provides the most accurate hemodynamic assessment. Advanced imaging modalities such as cardiac MRI or CT angiography may be employed in select cases to provide detailed anatomical information, particularly when interventional procedures are being considered.

Aortic stenosis in dogs is classified into three severity grades based on the pressure gradient across the obstruction, as measured by Doppler echocardiography. This grading system is fundamental to guiding treatment decisions, establishing prognosis, and making breeding recommendations. The pressure gradient is calculated from the peak aortic flow velocity using the modified Bernoulli equation, which converts velocity measurements into estimated pressure differences.

Mild aortic stenosis is characterized by a pressure gradient below approximately 50 mmHg, corresponding to a peak flow velocity below roughly 3.5 meters per second. Dogs with mild stenosis typically have a soft to moderately intense heart murmur and are generally asymptomatic. The left ventricle may show minimal or no hypertrophy on echocardiographic examination. These dogs usually have an excellent long-term prognosis, with a life expectancy that approaches or equals that of unaffected dogs. However, even mildly affected dogs should be excluded from breeding programs in predisposed breeds to prevent propagation of the genetic trait.

Moderate aortic stenosis encompasses pressure gradients between approximately 50 and 80 mmHg, with peak velocities in the range of 3.5 to 4.5 meters per second. Dogs in this category may be asymptomatic or may begin to show subtle signs of exercise intolerance. Echocardiographic examination typically reveals moderate concentric left ventricular hypertrophy, and arrhythmias may be present. The prognosis for dogs with moderate stenosis is more guarded, and these patients benefit from regular cardiac monitoring, exercise restriction, and may require medical management.

Severe aortic stenosis is defined by pressure gradients exceeding approximately 80 mmHg and peak velocities greater than 4.5 meters per second. Dogs with severe stenosis frequently exhibit clinical signs including exercise intolerance, syncope, and in some cases congestive heart failure. Significant left ventricular hypertrophy is present, and the risk of life-threatening arrhythmias and sudden death is substantially elevated. Studies have demonstrated that dogs with severe subaortic stenosis have a median survival time of approximately three to four years from diagnosis, though individual outcomes vary considerably based on the presence of arrhythmias and response to treatment.

It is important to recognize that the grading system, while clinically useful, represents a continuum rather than discrete categories. Dogs near the boundaries between grades may be reclassified on subsequent examinations, and serial monitoring is recommended to track disease progression. Additionally, the classification scheme was developed primarily for subaortic stenosis and may not apply identically to the less common valvular and supravalvular forms of the disease.

The treatment approach for aortic stenosis in dogs depends on the severity of the obstruction and the presence of clinical signs. Dogs with mild stenosis generally require no specific treatment beyond regular cardiac monitoring to ensure the condition remains stable. Annual or biannual echocardiographic examinations are typically recommended to track any changes in the pressure gradient, left ventricular wall thickness, or cardiac function over time. Activity restriction is usually unnecessary for mildly affected dogs, though prudent avoidance of extremely intense or prolonged exercise may be advised.

Medical management is the primary therapeutic approach for dogs with moderate to severe aortic stenosis. Beta-adrenergic blocking agents, particularly atenolol, represent the cornerstone of pharmacological therapy. Beta-blockers reduce heart rate, decrease myocardial oxygen demand, improve diastolic filling time, and may help suppress ventricular arrhythmias. While beta-blocker therapy has not been definitively proven to extend survival in controlled studies, clinical experience and retrospective analyses suggest potential benefits, and the drugs remain the standard of care for symptomatic or severely affected dogs.

Exercise restriction is an important component of management for dogs with moderate to severe disease. Intense physical activity increases myocardial oxygen demand at a time when the hypertrophied ventricle may already be experiencing relative ischemia due to the increased wall thickness and elevated intramural pressures. Sudden strenuous exercise is particularly dangerous, as it may trigger fatal ventricular arrhythmias. Owners are typically counseled to allow gentle, controlled leash walks while avoiding activities such as vigorous fetch, off-leash running, or competitive dog sports.

Interventional procedures, specifically balloon valvuloplasty performed via cardiac catheterization, have been attempted for canine subaortic stenosis but have shown limited long-term efficacy. Unlike valvular pulmonic stenosis, where balloon dilation often provides lasting hemodynamic improvement, the fibrous subvalvular ridge in SAS tends to recur after dilation, with pressure gradients returning to pre-intervention levels within months. Some specialized veterinary centers have explored cutting balloon techniques or other modifications, but these remain investigational. Open-heart surgery to resect the obstructive tissue has been performed in a limited number of cases, typically requiring cardiopulmonary bypass, but the high surgical risk and limited availability of the procedure restrict its clinical application.

Managing daily life with a dog diagnosed with aortic stenosis requires a thoughtful balance between maintaining quality of life and minimizing cardiac risk. For dogs with mild disease, adjustments to daily routine are often minimal. These dogs can generally enjoy normal activities with their families, including moderate walks and gentle play. The primary responsibility for owners of mildly affected dogs is adherence to the recommended monitoring schedule, ensuring that echocardiographic reassessments are performed at the intervals specified by their veterinary cardiologist.

For dogs with moderate to severe aortic stenosis, lifestyle modifications become more significant. Exercise management is a central consideration, with owners learning to recognize their dog's individual limitations and adjust activities accordingly. Leash walking at a calm, steady pace is generally safe and beneficial, while activities that provoke sudden bursts of intense exertion should be avoided. Environmental management is also important during hot weather, as heat stress increases cardiovascular demands and may precipitate clinical episodes in compromised dogs.

Owners of dogs with aortic stenosis should be educated about the signs of cardiac decompensation and the indicators of a potential emergency. Recognizing syncope, differentiating it from seizure activity, and understanding when to seek emergency veterinary care are critical pieces of knowledge. Owners should also be aware that sudden death remains a possibility in severely affected dogs despite optimal medical management, and compassionate preparation for this outcome, while difficult, is an important aspect of living with the diagnosis.

Regular veterinary follow-up is essential for all dogs with aortic stenosis, with the frequency of visits determined by disease severity. Mildly affected dogs may need echocardiographic reassessment once yearly, while those with moderate or severe disease may require evaluation every three to six months. Holter monitoring may be performed periodically to assess for arrhythmias, and medication dosages may be adjusted based on findings. Maintaining open communication with the veterinary cardiology team allows for timely intervention when changes in the dog's condition are detected.

The emotional impact of an aortic stenosis diagnosis on dog owners should not be underestimated. Learning that a beloved pet has a potentially life-threatening heart condition can be deeply distressing, particularly given the unpredictable nature of the disease. Support from veterinary professionals, breed communities, and online groups for owners of dogs with heart disease can provide valuable emotional sustenance and practical advice for navigating the challenges of managing this condition.

The prognosis for dogs with aortic stenosis is directly related to the severity of the obstruction. Dogs with mild aortic stenosis enjoy an excellent prognosis, with most living a normal or near-normal lifespan without significant clinical consequences from their cardiac condition. These dogs typically maintain good quality of life and may never develop symptoms attributable to their heart disease. Regular monitoring remains important even for mildly affected dogs, as occasional progression can occur, but the overall outlook for this group is favorable.

The prognosis for dogs with moderate aortic stenosis is more variable and depends on several factors, including the presence and frequency of arrhythmias, the degree of left ventricular hypertrophy, and the dog's response to medical management. Many dogs with moderate disease live for several years following diagnosis with appropriate treatment and activity management, though they face an increased risk of cardiac complications compared to mildly affected individuals. Serial monitoring is particularly important in this group to detect any progression toward severe disease.

Dogs with severe aortic stenosis face the most guarded prognosis. Studies examining outcomes in severely affected dogs have reported median survival times ranging from approximately 19 months to four years from the time of diagnosis, with significant variation between individuals. The primary causes of death or euthanasia in these dogs include sudden death from ventricular arrhythmias, progressive congestive heart failure, and quality-of-life decline related to exercise intolerance and recurrent syncopal episodes.

Several prognostic indicators have been identified that help refine the outlook for individual dogs. The presence of frequent or complex ventricular arrhythmias on Holter monitoring is associated with an increased risk of sudden death. Dogs that have experienced syncope face a worse prognosis than those without syncopal episodes. The rate of progression of left ventricular hypertrophy and any decline in systolic function on serial echocardiography also carry prognostic significance. Early diagnosis and initiation of appropriate medical management may improve outcomes, though the impact of treatment on long-term survival remains an area of ongoing study in veterinary cardiology.

Prevention of aortic stenosis in dogs centers on responsible breeding practices within predisposed breeds. Because the condition has a strong genetic basis, the most effective strategy for reducing its prevalence is the systematic exclusion of affected dogs and known carriers from breeding programs. Breed clubs and registries in several countries have established cardiac screening protocols that require echocardiographic examination of breeding stock by board-certified veterinary cardiologists before dogs are approved for breeding.

Screening programs recommend that dogs of predisposed breeds undergo cardiac evaluation at a minimum of 12 months of age, as the subvalvular fibrous ridge may continue to develop during the first year of life. Some protocols recommend rescreening at 24 months or later, as late-developing cases have been documented. Dogs that are cleared at one year of age but later develop detectable stenosis highlight the importance of multiple screening time points and the limitations of single-examination clearance in breeds with high prevalence.

The challenge of eliminating aortic stenosis through selective breeding is compounded by the polygenic nature of the inheritance and the phenomenon of variable expressivity. Dogs with very mild disease may pass screening examinations while still carrying and transmitting genetic risk to their offspring. Progeny testing, in which the cardiac status of a dog's offspring is evaluated to assess the parent's genetic contribution, provides additional information but is logistically demanding and time-consuming. Development of reliable genetic tests for aortic stenosis susceptibility remains an active area of research but has not yet yielded clinically available assays.

Breed-specific recommendations vary based on the prevalence and severity distribution of aortic stenosis within each breed. In the Newfoundland, where the condition is most thoroughly studied, breeding registries have implemented structured programs requiring cardiac certification. Golden Retriever, Rottweiler, and Boxer breed organizations have similarly adopted cardiac screening guidelines. Prospective puppy buyers in high-risk breeds should request documentation of cardiac evaluations on both parents, ideally performed by a board-certified veterinary cardiologist, and should be aware that even screened litters may occasionally produce affected puppies given the complex genetics of the disease.

Public education about aortic stenosis in predisposed breeds serves an important preventive role. Breeders who understand the genetic basis of the condition and the rationale for screening are more likely to participate in health testing programs. Puppy buyers who are informed about breed-specific health risks can make educated decisions about their purchases and contribute to demand-driven improvement in breeding practices. Veterinary professionals play a key role in disseminating this information and advocating for cardiac screening within their client populations.

Aortic stenosis can occur in conjunction with other congenital heart defects, and the presence of concurrent abnormalities may influence both clinical presentation and management. Mitral valve dysplasia is one of the more commonly observed concurrent defects in dogs with subaortic stenosis, and the combination of left-sided inflow and outflow tract abnormalities can compound the hemodynamic burden on the left ventricle. Pulmonic stenosis may also occur concurrently, particularly in breeds predisposed to multiple congenital cardiac defects.

Infective endocarditis represents a serious potential complication of aortic stenosis. The turbulent blood flow created by the stenotic region damages the endothelial surface of the aortic valve and the subvalvular area, creating sites vulnerable to bacterial colonization during episodes of bacteremia. Dogs with aortic stenosis who develop infective endocarditis face a markedly worse prognosis, as the infection can destroy valve tissue, lead to acute valvular insufficiency, and cause septic embolization to distant organs. The risk of endocarditis has led some cardiologists to recommend prophylactic antibiotic therapy for affected dogs undergoing dental procedures or other interventions associated with transient bacteremia, though this practice remains debated.

Secondary aortic valve insufficiency develops in some dogs with subaortic stenosis as the chronic turbulent flow damages the aortic valve leaflets over time. This regurgitation imposes an additional volume load on the already pressure-overloaded left ventricle, accelerating the progression toward heart failure. The development of significant aortic regurgitation on serial echocardiographic examinations is an important finding that may alter the prognosis and management plan for affected dogs.

Myocardial fibrosis is a histopathological consequence of chronic pressure overload and relative ischemia in the hypertrophied left ventricle. The thickened ventricular wall has increased oxygen requirements while simultaneously experiencing compression of intramural coronary vessels during systole, creating a supply-demand mismatch that leads to progressive myocardial ischemia and replacement fibrosis. This fibrotic tissue serves as a substrate for ventricular arrhythmias, establishing the mechanistic link between severe aortic stenosis and the risk of sudden cardiac death. Understanding these interrelated complications underscores the importance of comprehensive cardiac monitoring and proactive management in dogs affected by this challenging condition.